US Patent Issued to Roche Diabetes Care on Nov. 3 for "Methods of hematocrit correction as well as glucose meters and systems adapted therefor" (German Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,340, issued on Nov. 3, was assigned to Roche Diabetes Care Inc. (Indianapolis).

"Methods of hematocrit correction as well as glucose meters and systems adapted therefor" was invented by Jochen Schulat (Mannheim, Germany) and Sebastian Trick (Mannheim, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for correcting an analyte concentration measurement that may be influenced by hematocrit (HCT), especially a glucose concentration measurement. The methods include determining by means of a reference instrument a HCT reference value of a reference blood sample taken from a specific user, applying a fresh blood sample of the user...